September 29, 2026 In the News Withdrawal of Approved Antibiotic in U.S. Renews Questions About Market Sustainability Read More +
September 11, 2026 In the News A Comparative Review of Implemented and Emerging Pull Incentives Read More +
August 13, 2026 In the News Commentary: Fix the Market Challenges Behind Microbiome-Sparing Antibiotics Read More +
August 6, 2026 In the News Vedanta Biosciences Secures New Funding to Advance Phase 3 Program Read More +
July 16, 2026 In the News Trellis Bioscience Raises $9 Million to Advance Phase 2 Trial of mAb for PJIs Read More +
July 14, 2026 In the News The need for innovative financing models for antimicrobial development Read More +
